ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
S81-256,Sertraline,CYP2C19,"Minor â€“ result should be considered as may affect medicationresponse",INCREASED RISK OF SEROTONIN TOXICITY WITH DEXAMPHETAMINE
S81-256,Codeine (component of Acetaminophen-Caffeine-Codeine),"CYP2D6OPRM1",Usual prescribing considerations apply,NA
S81-256,Dexamphetamine,CYP2D6,Usual prescribing considerations apply,INCREASED RISK OF SEROTONIN TOXICITY WITH SERTRALINE
S81-256,Diclofenac,CYP2C9,Usual prescribing considerations apply,NA
S81-256,Propranolol,"CYP1A2CYP2D6",Usual prescribing considerations apply,NA
S81-256,gabapentin,NA,NO,NA
S81-256, oestrogen (Premarin Tablets),NA,NO,NA
S81-256, zopiclone,NA,NO,NA
S81-256, dimenhydrinate (Anti-Nauseant),NA,NO,NA
S81-256, acetaminophen (component of Acetaminophen-Caffeine-Codeine),NA,NO,NA
S81-256, caffeine (component of Acetaminophen-Caffeine-Codeine),NA,NO,NA
